Bevacizumab for Recurrent Malignant Glioma

Clinical trial NCT00271609 · COMPLETED

Trial details

NCT number: NCT00271609
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent High-Grade Gliomas Malignant Gliomas

Start date: 2005-12-01
Primary completion: 2011-03-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.